Media Coverage · November 17, 2014
Acticor Biotech in Les Echos journal
The full article from the French financial newspaper is available here :
Acticor Biotech agit contre l’AVC avec un anticorps monoclonal
Read next in 'Media Coverage'
- "Top 100 startups to invest in" - Challenges Magazine
- Acticor Biotech, a key R&D deal after a successful funding round for the treatment in the acute phase of ischemic stroke
- Biotech Finances: “Twice rewarded Acticor to raise funds again”
- Biotech Finances: “Acticor moves forward and comes back to crowdfunding!”
- BioPharmAnalyses.fr: French crowdfunding supports Acticor Biotech